** Shares of WuXi Biologics (Cayman) Inc 2269.HK jump 4.9% to HK$30.15, their highest since January 2024, and on course for a third consecutive session of gains
** Stock set for the biggest one-day pct gain since June 9, if current gains hold
** Co expects H1 revenue to increase 16% y/y, profit attributable to equity shareholders to rise 56% and gross profit margin to expand 3.6%
** The Hang Seng Biotech Index .HSHKBIO rises 1.1%, the benchmark Hang Seng Index .HSI adds 0.7%
** YTD, stock up 70.6%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。